Botulinum toxin A for upper limb spasticity

The Lancet Neurology

Volumn 14, Issue 10, 2015, Pages 969-971

  Kwakkel, Gert ^a,b   Meskers, Carel G M ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b Amsterdam Rehabilitation Research Centre Reade Amsterdam Reade   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BOTULINUM TOXIN A; ACETYLCHOLINE RELEASE INHIBITOR;

ARM DISEASE; CEREBROVASCULAR ACCIDENT; CONTROLLED CLINICAL TRIAL (TOPIC); COST EFFECTIVENESS ANALYSIS; DRUG COST; HUMAN; MULTICENTER STUDY (TOPIC); NOTE; PRIORITY JOURNAL; SARCOMERE LENGTH; SHORT FORM 36; SPASTICITY; TASK PERFORMANCE; TRAUMATIC BRAIN INJURY; UPPER LIMB SPASTICITY; ARM; BRAIN INJURY; COMPLICATION; FEMALE; MALE; MUSCLE SPASTICITY; PARESIS; PATHOPHYSIOLOGY;

ACETYLCHOLINE RELEASE INHIBITORS; BOTULINUM TOXINS, TYPE A; BRAIN INJURIES; FEMALE; HUMANS; MALE; MUSCLE SPASTICITY; PARESIS; STROKE; UPPER EXTREMITY;

EID: 84942505729     PISSN: 14744422     EISSN: 14744465     Source Type: Journal    
DOI: 10.1016/S1474-4422(15)00222-7     Document Type: Note

References (12)

1. Foley N, Pereira S, Salter K, Fernandez MM, Speechley M, Sequeira K, Miller T, Teasell R Treatment with botulinum toxin improves upper-extremity function post stroke: a systematic review and meta-analysis. Arch Phys Med Rehabil 2013, 94:977-989.
2. Gracies J-M, Brashear A, Jech R, et al. Safety and efficacy of abobotulinumtoxinA for hemiparesis in adults with upper limb spasticity after stroke or traumatic brain injury: a double-blind randomised controlled trial. Lancet Neurol 2015, for the International AbobotulinumtoxinA Adult Upper Limb Spasticity Study Group, published online Aug 27. http://dx.doi.org/10.1016/S1474-4422(15)00216-1.
3. Shaw L, Rodgers H, Price C, et al. BoTULS: a multicentre randomised controlled trial to evaluate the clinical effectiveness and cost-effectiveness of treating upper limb spasticity due to stroke with botulinum toxin type A. Health Technol Assess 2010, 14:1-113. BoTULS investigators.
4. Fleuren JF, Voerman GE, Erren-Wolters CV, et al. Stop using the Ashworth Scale for the assessment of spasticity. J Neurol Neurosurg Psychiatry 2010, 81:46-52.
5. de Vlugt E, de Groot JH, Schenkeveld KE, et al. The relation between neuromechanical parameters and Ashworth score in stroke patients. J Neuroeng Rehabil 2010, 7:35.
6. Pandyan AD, Johnson GR, Price CIM, et al. A review of the properties and limitations of the Ashworth and Modified Ashworth Scales as measures of spasticity. Clin Rehabil 1999, 13:373-383.
7. Dietz V, Sinkjaer T Spastic movement disorder: impaired reflex function and altered muscle mechanics. Lancet Neurol 2007, 6:725-733.
8. Lieber RL, Steinman S, Barash IA, Chambers H Structural and functional changes in spastic skeletal muscle. Muscle Nerve 2004, 29:615-627.
9. Demetrios M, Khan F, Turner-Stokes L, Brand C, McSweeney S Multidisciplinary rehabilitation following botulinum toxin and other focal intramuscular treatment for post-stroke spasticity. Cochrane Database Syst Rev 2013, 6. CD009689.
10. Gäverth J, Eliasson AC, Kullander K, Borg J, Lindberg PG, Forssberg H Sensitivity of the NeuroFlexor method to measure change in spasticity after treatment with botulinum toxin A in wrist and finger muscles. J Rehabil Med 2014, 46:629-634.
11. Baguley IJ, Nott MT, Turner-Stokes L, et al. Investigating muscle selection for botulinum toxin-A injections in adults with post-stroke upper limb spasticity. J Rehabil Med 2011, 43:1032-1037.
12. Grigoriu AI, Dinomais M, Rémy-Néris O, Brochard S Impact of injection-guiding techniques on the effectiveness of botulinum toxin for the treatment of focal spasticity and dystonia: a systematic review. Arch Phys Med Rehabil 2015, published online May 14. 10.1016/j.apmr.2015.05.002.